baber/WOPTO huggingface dataset:
Patent NZ-337595-A (NZ)
Title: Improved fluid displacing blade
Inventor: LEUNG CHI KEUNG
IPC: B63H1/28
Filed: 1998-04-08
Abstract: propeller (11) having five blades (13) supported from a hub (14) is exemplified. The propeller (11) is shown with the faces (15) of those blades (13) facing the viewer (out of the page), and has apertures (19) extending through each blade (13) from the face (15) to the back of each blade (13), and spread relatively evenly across the extent of each blade. The axial extent of the apertures (19) is substantially aligned with the direction of movement of the blades (13) relative to the axis of the propeller (11). The apertures (19) are normal both to the radial extent of the propeller (11) and the axial extent of the propeller. Each aperture (19) includes a bevelled edge in the form of a countersunk lip (21) extending around the periphery, on the face (15). The flow of fluid through the apertures (19) is believed to interfere with turbulent fluid adjacent to the back of the propeller (11), and so lead to improved efficiency of the propeller.
Patent NZ-503888-A (NZ)
Title: A paper pulp refining disc having ribs with the shape of involute arcs with circular evolutes
Inventor: OBITZ LARS
IPC: D21D1/30
Filed: 1998-09-17
Abstract: A refining disc (1,2) for refining fibres that includes ribs or ridges (3,4), which extend over the treatment zones of the discs. The ribs or ridges (3,4) extend radially and have the shape of involute arcs with circular evolutes and are of uniform width over the respective refining zones (5,6) on the refining disc (1,2).
Patent NZ-509019-A (NZ)
Title: Method of linking devices to gaming machines
Inventor: BOND ANTHONY WAYNE
IPC: G07F17/32
Filed: 1999-06-18
Abstract: A game machine has a central processing unit ("CPU"), a resource manager, driver pools, and a communication link that connect a plurality of intelligent Input/Output controller boards ("IOCB") to hardware devices interfaced to the game. The resource manager's functional blocks are: a resource manager control task, a plurality of Input/Output ("I/O") communication drivers to connect to the IOCBs, a low level and high level driver manager, a low level and high level driver pool, and a plurality of resource repositories that interface to the gaming software stored in the game memory of the machine. The resource manager starts an I/O communication driver to scan for the primary IOCB on the I/O memory bus, Universal Serial Bus, or Firewire. Once the primary IOCB is found, the resource control task will load more I/O communication drivers for any secondary IOCBs. The resource control task starts the driver managers, and requests the IOCB(s) to send the list of attached hardware. The driver managers load the drivers required for the type and version of hardware attached to the game. The gaming software interfaces to the hardware through the high level drivers loaded in the resource repositories. The high level drivers can be software or hardware drivers. Software drivers can simulate hardware, connect to other parts of the gaming software, or combine functions by calling other software and hardware drivers. New drivers can be added easily, allowing gaming software to use new hardware with little or no changes.
Patent NZ-511791-A (NZ)
Title: 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
Inventor: SEGELSTEIN BARBARA EILEEN
IPC: C07D265/30
Filed: 1999-12-01
Abstract: A compound of formula (I), wherein: Q is oxygen or CH2, R1 is hydrogen, C0-6alkoxy-C1-6alkyl-, or optionally substituted aryl, heteroaryl or heterocyclic, R2 is aryl, heteroaryl, heterocyclic, SO2R4, COR4, CONR5R6, COOR4, or C(OH)R5R6, X is CH or N, and Z1 and Z2 are hydrogen, halo, or C1-5alkyl. The compounds are used in the manufacture of medicaments for treating conditions mediated by opioid receptors.
Patent NZ-514465-A (NZ)
Title: Glucocorticoid receptor modulators
Inventor: DOW ROBERT LEE
IPC: A61P11/06
Filed: 2000-03-27
Abstract: Compounds of formula (I) are disclosed, wherein A is selected from the radicals of formulae A-1 to A-5, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for use as glucocortoid receptor modulators.
Patent NZ-518429-A (NZ)
Title: Terbutaline (beta-andrenergic agonist) as a uterine smooth muscle relaxant to treat endometriosis
Inventor: BOLOGNA WILLIAM J
IPC: A61K31/137
Filed: 2000-10-04
Abstract: Described are compositions and methods for using a beta -adrenergic agonist for treating endometriosis, for treating infertility, and for enhancing fertility. Further described is the formulating such a composition or method in such a way as to provide therapeutically sufficient levels of the beta -adrenergic agonist locally while avoiding adverse systematic concentrations in the host, thereby minimising or avoiding adverse side effects.
Patent NZ-518432-A (NZ)
Title: A homogeniser and method of cleaning same.
Inventor: RITCHIE THOMAS STUART
IPC: B01F13/10
Filed: 2002-04-16
Abstract: A homogeniser is disclosed including a housing, a drive mechanism located within the housing and a cutting element attached to the drive mechanism. At least part of the drive mechanism is reversibly movable within the housing between a position in which the cutting element is located within the housing and a position in which the cutting element at least partially projects outside the housing and thereby facilitates cleaning the housing. The homogeniser further includes an outer projection with a bearing surface capable of engaging with one or more objects external from the homogeniser to thereby restrain movement of the housing whilst allowing the drive mechanism and cutting element assembly to be movable with respect to the housing.
Patent NZ-521828-A (NZ)
Title: Anti-viral pyrimidine nucleoside analogues
Inventor: MCGUIGAN CHRISTOPHER
IPC: A61P31/12
Filed: 2001-04-12
Abstract: A compound of formula (I) and its use in the manufacture of a medicament for the prophylaxis or treatment of a viral infection.
Patent NZ-524060-A (NZ)
Title: An assembly for the control of fence line electrical parameters using a switch and a sensing assembly to detect electrical load on the output
Inventor: JOHNSTON RICHARD LLOYD
IPC: E06B/
Filed: 2003-02-05
Abstract: An electric fence control unit is disclosed wherein the initial shock felt by a subject coming into contact with a conductor that is connected to the output of the control unit is limited. The electric fence control unit includes an input assembly for connection to a power source and an output control assembly containing a controllable switch configured so as to be able to control the output of the control unit wherein the output of the control unit is a series of electrical pulses. An energy limiter network is configured to lower the pulse energy from the usual electric fence energizer output to a lower energy. A sensing assembly relays information to the control assemble regarding the detected electrical load on the output of the control unit. When the electrical load deviates outside a predetermined acceptable range, the controllable switch prevents the lower power electrical pulses from being conducted to the control unit output.
Patent NZ-525566-A (NZ)
Title: Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
Inventor: WALLACH DAVID
IPC: A61P29/00
Filed: 1999-03-18
Abstract: A protein capable of modulating or mediating the intracellular activity of RIP in inflammation, cell survival and cell death pathways is provided. DNA encoding it, a method for its production and its uses are also provided.
Patent NZ-526199-A (NZ)
Title: Fixed OFDM wireless MAN utilizing CPE having internal antenna, where the OFDM symbols are without training symbols
Inventor: GRINDAHL MERV
IPC: H04W99/00
Filed: 2000-10-23
Abstract: A wireless communication system, comprising a receiver and a transmitter, wherein said transmitter transmits to said receiver via radio frequency, and wherein said transmitter transmits an orthogonal frequency division multiplexed (OFDM) signal having a plurality of OFDM symbols, wherein said receiver detects said OFDM signal in an OFDM symbol-by-OFDM symbol manner, and wherein said plurality of OFDM symbols are without a training symbol. (62) Divided out of 518729
Patent NZ-526440-A (NZ)
Title: Pharmaceutical composition for modified release insulin sensitiser
Inventor: GLINECKE ROBERT
IPC: A61K45/00
Filed: 1999-11-12
Abstract: A modified release pharmaceutical composition comprises 2 to 12 mg of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a pharmaceutically acceptable derivative thereof and a pharmaceutically acceptable carrier which is in the form of an enteric tablet formulation. (62) Divided out of 511611
Patent NZ-535735-A (NZ)
Title: Top lift carrier and method of manufacture therefor
Inventor: MARCO LESLIE S
IPC: B31B50/86
Filed: 2004-10-04
Abstract: A carrier and a method for making a carrier (10) with handles (16,18) between rows of containers in both two-wide and three-wide configurations, and with the handle portion (16,18) and container holding portion (20) formed from different sheets (102,104) connected together.
Patent NZ-535864-A (NZ)
Title: Additive for ameliorating bioenergetic properties of inorganic and organic products, in particular of mineralic building materials
Inventor: GRIEDER KARL
IPC: C04B28/02
Filed: 2003-04-09
Abstract: Disclosed is an additive for cement-containing mineral building materials, wherein the additive comprises copper in elementary and powdered form or a mixture of copper with one or more metals from the group consisting of zinc, lead, tin, antimony, silver and gold in elementary and powdered form in portions of each 0.01 to 20 by weight and a support material such as wood charcoal. Also disclosed is a use of said additive in the production of a mineral building material with improved bio-energetic properties.
Patent NZ-544711-A (NZ)
Title: Method for installing a double ended distributed sensing fiber optical assembly within a guide conduit
Inventor: JAASKELAINEN KARI-MIKO
IPC: E21B47/06
Filed: 2004-07-26
Abstract: A method of installing a double ended distributed sensing optical fiber assembly (2) within a guide conduit (1), such as a small diameter control line in an underground borehole, comprises: providing a nose section (3), comprising an impact resistant coating (6) having an outer width (W) which is less than I cm, preferably less than 5 mm, which nose section (3) interconnects the proximal ends (4C and 4D) of two sections (4A and 4B) of distributed sensing fiber optical cable such that light transmitted along the length of one section of fiber optical cable (4A)is transmitted via the nose section (3) into the other section (4B) of fiber optical cable; inserting the nose section (3) into the guide conduit (1) such that the nose section (3) moves through the guide conduit (1) ahead of said two sections (4A and 4B) of distributed sensing fiber optical cable that are interconnected thereby; and connecting the distal ends (4G and 4F) of the sections of distributed sensing fiber optical cable to a light transmission and receiving unit (7) which is configured to convert the light spectra backscattered from different points of the fiber optical cable into distributed temperature, pressure and/or other physical data.
Patent NZ-548063-A (NZ)
Title: Use of substances having oxytocin antagonistic properties for the preparatioin of a medicament for treating hypertension
Inventor: REINHEIMER TORSTEN MICHAEL
IPC: A61P15/06
Filed: 2005-01-13
Abstract: Disclosed is a composition comprising barusiban or pharmaceutically acceptable salt thereof for use in the treatment of hypertension relating to pregnancy, pre-eclampsia, intrauterine growth retardation (IGUR), hyperfusion of the foetus, pregnancy induced hypertension (PIH), toxaemia, HELLP syndrome or eclampsia. Also disclosed is a use of said composition.
Patent NZ-550896-A (NZ)
Title: Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Inventor: HEWITT WILLIAM
IPC: A61K31/506
Filed: 2001-11-15
Abstract: Disclosed is a pharmaceutical composition comprising a rennin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof and a HMG-Co-A reductase inhibitor or a pharmaceutically acceptable salt thereof. Compositions of the type described are useful in the treatment of cardiovascular diseases.
Patent NZ-551309-A (NZ)
Title: Watercraft comprising a free-flying kite-type wind-attacked element as a wind-powered drive unit
Inventor: WRAGE STEPHAN
IPC: B63H9/06
Filed: 2005-04-19
Abstract: A watercraft 4 with wind propulsion, in which a freely flying kite-like element 101 on which wind acts and with a wing profile as an exclusive, auxiliary or emergency propulsion system, is connected to the vessel only via a hawser 1.1 which may spread out into a number of holding cables, in that the element 101 on which wind acts can be varied via at least one active drive element 1.2 including a winch, which is provided close to or adjacent the element 101 on which wind acts and is operatively connected to it, by variation of its aerodynamic effect for guidance to and holding in a predetermined position with respect to the watercraft 4 and/or for dynamic manoeuvring, in particular on predetermined flight paths, characterized in that a plurality of control lines form a matrix-like arrangement, with different control lines being driven in a combined form via a jointly driven operating element.
Patent NZ-571595-A (NZ)
Title: New amines
Inventor: BEZENCON OLIVIER
IPC: C07D401/12
Filed: 2007-03-07
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds are renin inhibitors useful in the treatment of diseases such as hypertension, congestive heart failure, pulmonary hypertension, renal insufficiency, renal ischemia, renal failure, renal fibrosis, cardiac insufficiency, cardiac hypertrophy, cardiac fibrosis, myocardial ischemia, cardiomyopathy, glomerulonephritis, renal colic, complications resulting from diabetes such as nephropathy, vasculopathy and neuropathy, glaucoma, elevated intra-ocular pressure, atherosclerosis, restenosis post angioplasty, complications following vascular or cardiac surgery, erectile dysfunction, hyperaldosteronism, lung fibrosis, scleroderma, anxiety, cognitive disorders, complications of treatments with immunosuppressive agents, and other diseases related to the renin-angiotensin system.
Patent NZ-576947-A (NZ)
Title: Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
Inventor: GENTSCHEV IVAYLO
IPC: A61K39/385
Filed: 2007-11-13
Abstract: Disclosed is a microorganism as a carrier of nucleotide sequences coding for antigens and protein toxins comprising the following components: (I) at least one nucleotide sequence coding for at least one complete or partial antigen of at least one wild-type or mutated protein; and (II) at least one nucleotide sequence coding for at least one protein toxin and/or at least one protein toxin subunit; and (III) a) at least one nucleotide sequence coding for at least one transport system which enables the expression of the expression products of component (I) and component (II) on the outer surface of the microorganism and/or enables the secretion of the expression products of component (I) and component (II); and/or coding for at least one signal sequence which enables the secretion of the expression products of component (I) and component (II); and/or b) optionally, at least one nucleotide sequence coding for at least one protein for lysing the microorganism in the cytosol of mammalian cells and for intracellularly releasing plasmids or expression vectors, which are contained in the lysed microorganism; and (IV) at least one nucleotide sequence for at least one activation sequence for the expression of one or more of components (I) to (III), wherein said activation sequence can be activated in the microorganism and/or is tissue cell-specific, tumour cell-specific, macrophage-specific, dendrite-specific, lymphocyte-specific, function-specific or non-cell-specific; wherein any of components (I) to (IV) can be present either once or several times and if a component of components (I) to (IV) is present several times it can independently from each other be either identical or different; and wherein component (I) and component (II) are not identical, that is component (I) does not code for at least one nucleotide sequence coding for at least one protein toxin and/or at least one protein toxin subunit.
Patent NZ-577641-A (NZ)
Title: Techniques for limiting demand from electricity meter with an installed relay
Inventor: MASON ROBERT T JR
IPC: G01D4/00
Filed: 2009-06-12
Abstract: An electricity meter comprises at least one load control and at least one controller. The at least one load control is changeable between a de-energize mode and a re-energize mode; and The at least controller is configured, at least in part, to: set the at least one load control from the de-energize mode to the re-energize mode upon receipt of a command; measure an electrical current of an electricity load in communication with the electricity meter; compare the measured electrical current of the electricity load to a predetermined threshold; and set the at least one load control from the re-energize mode to the de-energize mode upon the measured electrical current of the electricity load exceeding the predetermined threshold at any time before an end of a predetermined time interval.
Patent NZ-583957-A (NZ)
Title: Pyridine derivatives as s1p1/edg1 receptor modulators
Inventor: BOLLI MARTIN
IPC: A61K31/427
Filed: 2008-08-14
Abstract: Disclosed herein is a pyridine compound for Formula (I), wherein the subsitituents are as defined within the specification. Also disclosed are compositions and processes for the preparation of compounds of formula (I). Compounds of formula (I) are useful in the prevention or treatment of diseases or disorders associated with an activated immune system i.e. rejection of transplanted organs such as kidney, liver, heart, lung, pancreas, cornea, and skin; graft-versus-host diseases brought about by stem cell transplantation; autoimmune syndromes including rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, psoriasis, psoriatic arthritis, thyroiditis such as Hashimoto's thyroiditis, uveo-retinitis; atopic diseases such as rhinitis, conjunctivitis, dermatitis; asthma; type I diabetes; post- infectious autoimmune diseases including rheumatic fever and post-infectious glomerulonephritis; solid cancers and tumor metastasis.
Patent NZ-589570-A (NZ)
Title: Methods for enhancing the degradation or conversion of cellulosic material
Inventor: HARRIS PAUL
IPC: C12N1/00
Filed: 2006-09-29
Abstract: Disclosed is a method for degrading or converting a cellulosic material, comprising: treating the cellulosic material with an effective amount of one or more cellulolytic proteins in the presence of an effective amount of a polypeptide having cellulolytic enhancing activity, wherein the presence of the polypeptide having cellulolytic enhancing activity increases the degradation of cellulosic material compared to the absence of the polypeptide having cellulolytic enhancing activity and wherein the polypeptide having cellulolytic enhancing activity is selected from the group consisting of: a polypeptide comprising [ILMV]-P-x(4,5)-G-x-Y-[ILMV]-x-R-x-[EQ]-x(3)-A-[HNQ], wherein x is any amino acid, x(4,5) is any amino acid at 4 or 5 contiguous positions, and x(3) is any amino acid at 3 contiguous positions. Further disclosed is a method for producing a fermentation product, comprising: (A) saccharifying a cellulosic material with an effective amount of one or more cellulolytic proteins in the presence of an effective amount of the polypeptide having cellulolytic enhancing activity, wherein the presence of the polypeptide having cellulolytic enhancing activity increases the degradation of cellulosic material compared to the absence of the polypeptide having cellulolytic enhancing activity and wherein the polypeptide having cellulolytic enhancing activity is selected from the group consisting of: a polypeptide comprising [ILMV]-P-x(4,5)-G-x-Y-[ILMV]-x-R-x-[EQ]-x(3)-A-[HNQ], wherein x is any amino acid, x(4,5) is any amino acid at 4 or 5 contiguous positions, and x(3) is any amino acid at 3 contiguous positions. (B) fermenting the saccharified cellulosic material of step (a) with one or more fermenting microorganisms; and (C) recovering the fermentation product from the fermentation.
Patent NZ-591014-A (NZ)
Title: Optical fiber sensor with an illumination optical fiber having an angled reflecting distal face to provide a probing light
Inventor: EGALON CLAUDIO OLIVEIRA
IPC: G01N21/77
Filed: 2006-04-26
Abstract: Disclosed is a reversible distributed optical fiber sensing system with high spatial resolution. The system has: a sensitive optical fiber having a core with a cladding having at least one sensitive region being sensitive to a measurand; at least one probing light source directed from the exterior of the cladding into the sensitive region to illuminating each sensitive region individually, one at a time; detector means in axial optical communication with a first terminus of the sensitive optical fiber; signal processing means communicating with the detector means; display means communicating with the signal processing means; and a power supply. The probing light is transmitted by an illumination optical fiber, the illumination optical fiber has an angled reflecting distal end face and is positioned parallel to the sensitive optical fiber. The angled reflecting distal end face illuminates the sensitive region, at an angle, with the probing light. A further probing light source axially introduces probing light into the illumination optical fiber, the probing light being coupled into the core of the illumination optical fiber. The probing light is transmitted along the length of the illumination optical fiber towards the angled reflecting distal end face, and the probing light is reflected at an angle towards the sensitive region by the angled reflecting distal end face to cause the probing light to interact with the sensitive region. (62) Divided Out of 563641